NASDAQ:CPRX

Catalyst Pharmaceuticals Stock News

etoro logo Buy CPRX
*Your capital is at risk
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026

Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now?

02:00pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, an
Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You Should Know

11:00pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $20.27, moving -0.78% from the previous trading session.

Analyst Expectations for Catalyst Pharmaceuticals's Future

05:00pm, Thursday, 19'th Jan 2023 Benzinga
Analysts have provided the following ratings for Catalyst Pharmaceuticals (NASDAQ:CPRX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3
XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB are part of the Zacks Investment Ideas article.

Biotech's Blockbuster Week: 3 Stocks to Watch

05:32pm, Friday, 13'th Jan 2023 Zacks Investment Research
In a strong week for the market, biotech dominated. Today we will cover 3 promising stocks in the space.
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.

Is Most-Watched Stock Catalyst Pharmaceuticals, Inc. (CPRX) Worth Betting on Now?

02:00pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Catalyst (CPRX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Catalyst (CPRX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?

Sector Leaders End Tough Year With Thin Ranks

03:04pm, Friday, 30'th Dec 2022
New Year starts with just three top stocks that meet IBD Sector Leaders' stringent criteria: Super Micro Computer, KLA and Catalyst Pharma. The post Sector Leaders End Tough Year With Thin Ranks appea

Biotech: 3 Profitable Bios Worth Owning

07:19pm, Wednesday, 28'th Dec 2022 Zacks Investment Research
The biotechnology space can be a difficult area to generate profits. Drugs take years to develop and often fail FDA approval. Today we will look at three top biotech stocks that are very profitable an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE